SCHEMBL4004339

SCHEMBL4004339

NC(=O)c1cccc(NC(=O)c2ccccc2)c1

nearest known ligand 0.76

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 6/20 0.76
KCNK9 Q9NPC2 4/20 0.76
KMT2A Q03164 6/20 0.68
MEN1 O00255 5/20 0.68
SIRT1 Q96EB6 1/20 0.67
PARP1 P09874 4/20 0.66
PARP15 Q460N3 3/20 0.66
PARP10 Q53GL7 3/20 0.66
RAB9A P51151 3/20 0.66
PLAU P00749 1/20 0.66
NPC1 O15118 2/20 0.65
HPGD P15428 1/20 0.65
SIRT2 Q8IXJ6 1/20 0.64
TP53 P04637 1/20 0.63
PARP14 Q460N5 2/20 0.62
POLB P06746 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28031075 0.93 KCNK3 (0.77) KCNK3KCNK9KMT2AMEN1SIRT1
SCHEMBL10090679 0.92 PARP1 (0.74) KCNK3KCNK9KMT2AMEN1SIRT1
SCHEMBL3069463 0.89 PLAU (0.76) KCNK3KCNK9KMT2AMEN1SIRT1
SCHEMBL28155028 0.88 KMT2A (0.61) KCNK3KCNK9KMT2AMEN1SIRT1
SCHEMBL28031074 0.88 PLAU (0.69) KCNK3KCNK9KMT2AMEN1SIRT1
N-Phenylbenzamide SCHEMBL789791 0.87 SIRT1 (0.69) KCNK3KCNK9KMT2AMEN1SIRT1
SCHEMBL19303149 0.87 KMT2A (0.59) KCNK3KCNK9KMT2AMEN1SIRT1
SCHEMBL29835055 0.87 KCNK3 (0.74) KCNK3KCNK9KMT2AMEN1SIRT1
SCHEMBL2298254 0.87 KCNK3 (1.00) KCNK3KCNK9KMT2AMEN1SIRT1
SCHEMBL7739117 0.86 KCNK3 (0.82) KCNK3KCNK9KMT2AMEN1SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101056632-B Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2011-12-07 CN claimed
EP-1814545-A4 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-06-10 EP claimed
US-20080221192-A1 Compounds and Compositions as Protein Kinase Inhibitors IRM LLC (BM) 2008-09-11 US claimed
EP-1814545-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM, LLC (BM) 2007-08-08 EP claimed
WO-2006052936-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2006-05-18 WO claimed
CN-1155278-A Arylthio compounds as antibacteral and antiviral agents WARNER LAMBERT CO (US) 1997-07-23 CN claimed
EP-0775110-A1 ARYLTHIO COMPOUNDS AS ANTIBACTERIAL AND ANTIVIRAL AGENTS WARNER-LAMBERT COMPANY (US) 1997-05-28 EP claimed
WO-1996004242-A1 ARYLTHIO COMPOUNDS AS ANTIBACTERIAL AND ANTIVIRAL AGENTS WARNER-LAMBERT COMPANY (US) 1996-02-15 WO claimed
CN-121569813-A Agricultural composition containing pyridaben and application thereof 浙江宇龙药业有限公司 2026-02-27 CN disclosed
CN-121569812-A Pesticide composition containing ecdysone compound and application thereof 浙江宇龙药业有限公司 2026-02-27 CN disclosed
CN-118716353-A Novel sanitary insecticidal compound composition and application thereof 江苏功成生物科技有限公司 2024-10-01 CN disclosed
CN-117941692-A Insecticidal composition containing pyriproxyfen and chlorfenapyr flubendiamide and application thereof 广西思钺生物科技有限责任公司 2024-04-30 CN disclosed
CN-115886009-B Insecticidal composition containing bromofluorobenzene bisamide 青岛奥迪斯生物科技有限公司 2024-04-16 CN disclosed
CN-115886009-A Insecticidal composition containing bromofenoxaprop-p-fluorobenzene bisamide 青岛奥迪斯生物科技有限公司 2023-04-04 CN disclosed
EP-1714958-A1 AMIDE DERIVATIVES, PROCESS FOR PRODUCTION OF THE SAME, AND METHOD FOR APPLICATION THEREOF AS INSECTICIDE Mitsui Chemicals, Inc. (JP) 2006-10-25 EP disclosed
WO-2006052936-A2 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2006-05-18 WO disclosed
EP-1115707-B1 BENZAMIDE DERIVATIVES AND THER USE AS CYTOKINE INHIBITORS ASTRAZENECA AB (SE) 2003-11-12 EP disclosed
EP-1102743-B1 AMIDE DERIVATIVES WHICH ARE USEFUL AS CYTOKINE INHIBITORS ASTRAZENECA AB (SE) 2002-07-24 EP disclosed
CN-1155278-A Arylthio compounds as antibacteral and antiviral agents WARNER LAMBERT CO (US) 1997-07-23 CN disclosed
CN-1151187-A Subtilisin 309 variants having decreased absorption and increased hydrolysis PROCTER & GAMBLE (US) 1997-06-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221192-A1 Compounds and Compositions as Protein Kinase Inhibitors BMX, FRK, PTK2B KCNK3 874/4885KCNK9 1165/4885KMT2A 1437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.